Total Payments
$51,554
2024 Payments
$10,785
Companies
8
Transactions
32
Medicare Patients
21,585
Medicare Billing
$778,985
Payment Breakdown by Category
Research$31,928 (61.9%)
Travel$10,373 (20.1%)
Consulting$4,125 (8.0%)
Other$3,525 (6.8%)
Food & Beverage$1,604 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $31,928 | 4 | 61.9% |
| Travel and Lodging | $10,373 | 7 | 20.1% |
| Consulting Fee | $4,125 | 3 | 8.0% |
| Honoraria | $3,525 | 2 | 6.8% |
| Food and Beverage | $1,604 | 16 | 3.1% |
Payments by Type
Research
$31,928
4 transactions
General
$19,627
28 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BioSig Technologies, Inc. | $38,178 | 8 | $0 (2021) |
| Boston Scientific Corporation | $9,832 | 6 | $0 (2024) |
| AltaThera Pharmaceuticals LLC | $1,400 | 1 | $0 (2023) |
| Medtronic, Inc. | $1,190 | 8 | $0 (2024) |
| Medtronic Vascular, Inc. | $286.76 | 3 | $0 (2018) |
| Abbott Laboratories | $257.07 | 2 | $0 (2022) |
| Biosense Webster, Inc. | $220.74 | 3 | $0 (2023) |
| ATRICURE, INC. | $189.82 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,785 | 12 | Boston Scientific Corporation ($9,832) |
| 2023 | $1,743 | 4 | AltaThera Pharmaceuticals LLC ($1,400) |
| 2022 | $227.62 | 2 | Medtronic, Inc. ($127.50) |
| 2021 | $21,287 | 8 | BioSig Technologies, Inc. ($21,178) |
| 2020 | $17,000 | 1 | BioSig Technologies, Inc. ($17,000) |
| 2019 | $67.79 | 1 | Biosense Webster, Inc. ($67.79) |
| 2018 | $282.77 | 2 | Abbott Laboratories ($156.95) |
| 2017 | $160.94 | 2 | Medtronic Vascular, Inc. ($160.94) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $149.86 | General |
| 06/05/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $313.65 | General |
| 06/04/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $133.29 | General |
| Category: FARAPULSE EP | ||||||
| 06/03/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $375.48 | General |
| 06/03/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $70.18 | General |
| Category: FARAPULSE EP | ||||||
| 06/02/2024 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $8,789.80 | General |
| 03/07/2024 | Medtronic, Inc. | EVERA MRI XT DR SURESCAN (Device) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 03/06/2024 | Medtronic, Inc. | EVERA MRI XT DR SURESCAN (Device) | Food and Beverage | In-kind items and services | $37.65 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 03/05/2024 | Medtronic, Inc. | EVERA MRI XT DR SURESCAN (Device) | Travel and Lodging | In-kind items and services | $48.62 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 02/29/2024 | Medtronic, Inc. | EVERA MRI XT DR SURESCAN (Device) | Travel and Lodging | In-kind items and services | $209.00 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 02/29/2024 | Medtronic, Inc. | EVERA MRI XT DR SURESCAN (Device) | Travel and Lodging | In-kind items and services | $24.09 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 02/27/2024 | Medtronic, Inc. | EVERA MRI XT DR SURESCAN (Device) | Travel and Lodging | In-kind items and services | $611.98 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 09/06/2023 | AltaThera Pharmaceuticals LLC | Sotalol Hydrochloride (Drug) | Honoraria | Cash or cash equivalent | $1,400.00 | General |
| Category: Cardiovascular | ||||||
| 06/27/2023 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device), ATRICLIP LAA EXCLUSION SYSTEM | Food and Beverage | In-kind items and services | $189.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/11/2023 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $102.95 | General |
| Category: Cardiology | ||||||
| 04/25/2023 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Cardiology | ||||||
| 06/26/2022 | Abbott Laboratories | ENSITE PRECISION (Device) | Food and Beverage | In-kind items and services | $100.12 | General |
| Category: Electrophysiology | ||||||
| 05/03/2022 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $127.50 | General |
| Category: Pacemakers | ||||||
| 11/08/2021 | BioSig Technologies, Inc. | PURE EP SYSTEM (Device) | — | Cash or cash equivalent | $6,400.00 | Research |
| Study: Post-Market Study of Novel Cardiac Signal Processing System for Electrophysiology Procedures (The PURE EP 2.0 Study) • Category: Electrophysiology | ||||||
| 08/04/2021 | BioSig Technologies, Inc. | PURE EP SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Electrophysiology | ||||||
| 06/18/2021 | BioSig Technologies, Inc. | PURE EP SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: Electrophysiology | ||||||
| 06/16/2021 | Medtronic, Inc. | Micra (Device) | Food and Beverage | In-kind items and services | $109.40 | General |
| Category: Pacemakers | ||||||
| 04/19/2021 | BioSig Technologies, Inc. | PURE EP SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| Category: Electrophysiology | ||||||
| 04/12/2021 | BioSig Technologies, Inc. | PURE EP SYSTEM (Device) | Honoraria | Cash or cash equivalent | $2,125.00 | General |
| Category: Electrophysiology | ||||||
| 03/08/2021 | BioSig Technologies, Inc. | PURE EP System (Device) | — | Cash or cash equivalent | $500.00 | Research |
| Study: Post-Market Study of Novel Cardiac Signal Processing System for Electrophysiology Procedures (The PURE EP 2.0 Study) • Category: Electrophysiology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PURE EP 2.0 STUDY | BioSig Technologies, Inc. | $17,000 | 1 |
| Post-Market Study of Novel Cardiac Signal Processing System for Electrophysiology Procedures (The PURE EP 2.0 Study) | BioSig Technologies, Inc. | $14,428 | 2 |
| Post-Market Study of Novel Cardiac Signal Processing System for Electrophysiology Procedures (The PURE EP 2.0 Study) | BioSig Technologies, Inc. | $500.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,116 | 2,738 | $1.3M | $131,576 |
| 2022 | 33 | 5,696 | 7,327 | $2.0M | $211,382 |
| 2021 | 33 | 6,669 | 8,121 | $330,703 | $213,486 |
| 2020 | 33 | 7,104 | 8,982 | $338,767 | $222,540 |
Total Patients
21,585
Total Services
27,168
Medicare Billing
$778,985
Procedure Codes
146
All Medicare Procedures & Services
146 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 24 | 24 | $379,357 | $19,166 | 5.1% |
| 93654 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | Facility | 2023 | 19 | 19 | $133,282 | $16,636 | 12.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 164 | 171 | $52,043 | $9,686 | 18.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 495 | 634 | $108,414 | $8,838 | 8.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 329 | 419 | $72,906 | $8,158 | 11.2% |
| 93650 | Destruction of heart conduction tissue to create heart block | Facility | 2023 | 17 | 17 | $81,577 | $7,805 | 9.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 70 | $31,500 | $6,934 | 22.0% |
| 93655 | Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | Facility | 2023 | 22 | 25 | $77,125 | $6,431 | 8.3% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 168 | 218 | $70,196 | $4,845 | 6.9% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 96 | 194 | $26,966 | $4,466 | 16.6% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 47 | 52 | $20,384 | $3,581 | 17.6% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 45 | 51 | $23,358 | $3,572 | 15.3% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 11 | 11 | $23,864 | $3,453 | 14.5% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 95 | 193 | $28,757 | $3,194 | 11.1% |
| 93286 | Programming of single, dual, or multiple lead or leadless pacemaker system before or after surgery | Office | 2023 | 60 | 117 | $14,391 | $3,108 | 21.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $16,261 | $3,013 | 18.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 17 | $10,268 | $2,431 | 23.7% |
| 93462 | Insertion of tube in left heart chamber through heart septum | Facility | 2023 | 11 | 11 | $14,531 | $1,909 | 13.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $9,801 | $1,827 | 18.6% |
| 93662 | Ultrasound evaluation of heart blood vessel with review by radiologist | Facility | 2023 | 26 | 26 | $39,390 | $1,510 | 3.8% |
| 93287 | Programming of single, dual or multiple lead implantable defibrillator system before or after surgery | Office | 2023 | 19 | 37 | $8,880 | $1,369 | 15.4% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 23 | 27 | $6,993 | $1,302 | 18.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 18 | 19 | $4,693 | $1,295 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 18 | $5,328 | $1,109 | 20.8% |
| 93284 | Programming of multiple lead implantable defibrillator system | Facility | 2023 | 23 | 24 | $16,224 | $1,063 | 6.6% |
About Christopher Mcleod
Christopher Mcleod is a Cardiovascular Disease healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1871612010.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Mcleod has received a total of $51,554 in payments from pharmaceutical and medical device companies, with $10,785 received in 2024. These payments were reported across 32 transactions from 8 companies. The most common payment nature is "" ($31,928).
As a Medicare-enrolled provider, Mcleod has provided services to 21,585 Medicare beneficiaries, totaling 27,168 services with total Medicare billing of $778,985. Data is available for 4 years (2020–2023), covering 146 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Jacksonville, FL
- Active Since 03/28/2007
- Last Updated 08/31/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1871612010
Products in Payments
- PURE EP SYSTEM (Device) $37,678
- Sotalol Hydrochloride (Drug) $1,400
- EVERA MRI XT DR SURESCAN (Device) $953.18
- PURE EP System (Device) $500.00
- Advisa (Device) $286.76
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $189.82
- Ensite Cardiac Mapping System (Device) $156.95
- CARTO 3 (Device) $152.95
- MICRA (Device) $127.50
- Micra (Device) $109.40
- ENSITE PRECISION (Device) $100.12
- Carto 3 System (Device) $67.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Jacksonville
Dominick Angiolillo, Md, MD
Cardiovascular Disease — Payments: $417,748
Cardiovascular Disease $417,748
Dr. Saumil Oza, M.d, M.D
Cardiovascular Disease — Payments: $336,166
Cardiovascular Disease $336,166
Dr. Samer Garas, Md, MD
Cardiovascular Disease — Payments: $264,433
Cardiovascular Disease $264,433
Dr. Albert Seals, Md, MD
Cardiovascular Disease — Payments: $184,323
Cardiovascular Disease $184,323
Dr. Bharat Gummadi, M.d, M.D
Cardiovascular Disease — Payments: $140,527
Cardiovascular Disease $140,527
Dr. Raguveer Murthy, M.d, M.D
Cardiovascular Disease — Payments: $106,493
Cardiovascular Disease $106,493